These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2673117)

  • 1. Cholesterol and coronary heart disease. The attributable risk reduction of diet and drugs.
    Malenka DJ; Baron JA
    Arch Intern Med; 1989 Sep; 149(9):1981-5. PubMed ID: 2673117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol and coronary heart disease. The importance of patient-specific attributable risk.
    Malenka DJ; Baron JA
    Arch Intern Med; 1988 Oct; 148(10):2247-52. PubMed ID: 3178382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid disorders: when--and why--you should treat at-risk adults.
    Gamble CL
    Geriatrics; 1994 Oct; 49(10):33-8. PubMed ID: 7926847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of cholesterol in coronary heart disease risk reduction.
    Woodhead GA
    Nurse Pract; 1996 Sep; 21(9):45, 48, 51-3. PubMed ID: 8884794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
    Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [When should hypercholesterolemia patients be diagnosed and treated?].
    Jacotot B
    Rev Prat; 1989 Apr; 39(12):1046-8. PubMed ID: 2740768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doubts about clinical impact of cholesterol reduction.
    Vine DL
    Am Fam Physician; 1994 Feb; 49(3):558, 560, 567. PubMed ID: 8310961
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease].
    Jost S; Lichtlen PR
    Z Kardiol; 1995 Aug; 84(8):577-95. PubMed ID: 7571764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholesterol--the main risk factor in ischemic heart disease].
    Heyden S; Kroos S
    Schweiz Rundsch Med Prax; 1988 Nov; 77(48):1312-7. PubMed ID: 3064242
    [No Abstract]   [Full Text] [Related]  

  • 14. Treating hyperlipidemia, Part I: Whether and when in the elderly.
    Smith DA; Karmally W; Brown WV
    Geriatrics; 1987 Jun; 42(6):33-6, 39-42, 44. PubMed ID: 3582985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL cholesterol: physiology, pathophysiology, and management.
    Link JJ; Rohatgi A; de Lemos JA
    Curr Probl Cardiol; 2007 May; 32(5):268-314. PubMed ID: 17481993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
    Leake NB
    Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypercholesterolemia: to treat or not to treat? That is the question].
    Ducobu J
    Rev Med Brux; 1994; 15(3):124-31. PubMed ID: 8066357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z; Undas R
    Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic hypercholesterolemia: a clinical policy review. The Toronto Working Group on Cholesterol Policy.
    J Clin Epidemiol; 1990; 43(10):1028-121. PubMed ID: 2120391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.